New Metabolic Target Offers Hope for Treating Rare and Aggressive Childhood Cancer
Researchers from the University of Iowa have identified a critical metabolic pathway in an aggressive childhood cancer, opening new horizons for targeted therapies and improved patient outcomes.
A groundbreaking study has uncovered a vital metabolic vulnerability in Malignant Peripheral Nerve Sheath Tumor (MPNST), a rare and highly aggressive childhood cancer predominantly affecting teenagers and young adults. This form of cancer is characterized by rapid growth and a tendency to spread, with limited effective treatment options, especially once it metastasizes. Currently, there are no targeted therapies available for metastatic MPNST, making new treatment approaches critically important.
Researchers from the University of Iowa, led by Dr. Eric Taylor and Dr. Rebecca Dodd, employed advanced gene editing techniques to develop models that accurately replicate the genetic mutations found in patients. Using these models, they utilized cutting-edge genomic and metabolomic analyses to investigate the cancer’s fuel sources. Their findings, published in Science Advances, revealed that MPNST cells depend heavily on a specific metabolic pathway to survive oxidative stress and sustain tumor growth.
The study identified the Pentose Phosphate Pathway (PPP) as a key process in these tumor cells. This pathway metabolizes sugars to generate molecules essential for combatting oxidative damage. When researchers inhibited the PPP, the tumors grew more slowly and became more susceptible to chemotherapy, indicating a promising therapeutic target.
This discovery is significant because it links the PPP pathway directly to MPNST tumor progression for the first time, opening new avenues for treatment development. The collaborative research combined expertise in cancer biology and metabolism, led by graduate student Gavin McGivney, now a postdoctoral researcher at the University of Chicago.
Dodd emphasizes that targeting the PPP could lead to novel strategies to slow tumor growth and improve patient outcomes in this difficult-to-treat cancer. The findings suggest that future therapies might incorporate metabolism-based approaches to enhance current treatments. This research marks a vital step toward more effective interventions for children and young adults affected by MPNST.
Source: https://medicalxpress.com/news/2025-08-metabolic-pathway-rare-aggressive-childhood.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Exploring Low-Dose Naltrexone as a Potential Treatment for Long COVID
Research from Griffith University suggests that low-dose naltrexone, a drug used for opioid addiction, may be an effective treatment for Long COVID by restoring cellular function and improving symptoms.
New Mapping Indicates India Faces the Largest Long-Term Impact from Chikungunya Virus
Recent research reveals that India faces the highest long-term impact from chikungunya, with extensive mapping predicting millions at risk and highlighting the urgent need for targeted prevention strategies.
Personalized Insights into ALS Treatment Through Patient-Derived Cell Testing
Innovative use of patient-derived cells allows for personalized testing of ALS drugs, paving the way for targeted therapies and improved patient outcomes.
Discovery of Tiny Genetic Segment That Regulates Brain Connectivity and Behavior
A groundbreaking study reveals how a tiny genetic segment, mini-exon B, critically influences brain connectivity, neural balance, and behavior, offering new insights into neurodevelopmental disorders.